Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.001 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.17 | 0.001 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.001 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.002 |
mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.002 |
mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.096 | 0.002 |
mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |